Vaxart appointed Steven Lo as Chief Executive Officer and Michael J. Finney as Chairman of the Board on September 3, 2025.
5 reports, 1 independent
Updated Sep 3
Gone quiet
- Reports
- 5
- Developments
- 3
- Repetition
- 40%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vaxart appointed Steven Lo as Chief Executive Officer and Michael J. Finney as Chairman of the Board on September 3, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Vaxart appointed Steven Lo as CEO and Michael J. Finney as Chairman of the Board.1 source
ISS supported Vaxart's reverse stock split proposal.1 source
- Vaxart listed on OTCQX Best Market and confirmed Steven Lo as CEO.
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- GlobeNewswireVaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or th
- GlobeNewswireConcerned Vaxart Stockholders Urge Fellow Stockholders to Vote “AGAINST” Reverse Stock Split and Demand Board Accountability Oppose Management’s Latest Attempt to Push Through Proposal Despite Prior
- GlobeNewswireVaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal - ISS and Glass Lewis, leading independent proxy advisory firms, support reverse stock
- GlobeNewswireVaxart Provides Business Update and Reports Second Quarter 2025 Financial Results Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vacc
- Unknown outlet